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Abstract
Background: Chronic illness and disability can have damaging, even catastrophic, socioeconomic effects on individuals
and their households. We examined the experiences of people affected by chronic heart failure, complicated diabetes
and chronic obstructive pulmonary disease to inform patient centred policy development. This paper provides a first
level, qualitative understanding of the economic impact of chronic illness.
Methods: Interviews were conducted with patients aged between 45 and 85 years who had one or more of the index
conditions and family carers from the Australian Capital Territory and Western Sydney, Australia (n = 66). Content
analysis guided the interpretation of data.
Results: The affordability of medical treatments and care required to manage illness were identified as the key aspects
of economic hardship, which compromised patients' capacity to proactively engage in self-management and risk reduction
behaviours. Factors exacerbating hardship included ineligibility for government support, co-morbidity, health service
flexibility, and health literacy. Participants who were on multiple medications, from culturally and linguistically diverse or
Indigenous backgrounds, and/or not in paid employment, experienced economic hardship more harshly and their
management of chronic illness was jeopardised as a consequence. Economic hardship was felt among not only those
ineligible for government financial supports but also those receiving subsidies that were insufficient to meet the costs of
managing long-term illness over and above necessary daily living expenses.
Conclusion: This research provides insights into the economic stressors associated with managing chronic illness,
demonstrating that economic hardship requires households to make difficult decisions between care and basic living
expenses. These decisions may cause less than optimal health outcomes and increased costs to the health system. The
findings support the necessity of a critical analysis of health, social and welfare policies to identify cross-sectoral strategies
to alleviate such hardship and improve the affordability of managing chronic conditions. In a climate of global economic
instability, research into the economic impact of chronic illness on individuals' health and well-being and their disease
management capacity, such as this study, provides timely evidence to inform policy development.
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Background
The prevention, management and treatment of chronic,
non-communicable illness are major issues facing govern-
ments in the 21st Century [1,2]. In 2002 approximately 59
per cent of global death was attributable to chronic, non-
communicable diseases and the toll is projected to
increase to 66 per cent by 2030 [3]. The estimates are
markedly higher for developed countries, where almost
all deaths (86%) are attributable to this disease category
[4]--in Australia around 80% of the total burden of illness
and injury is accounted for by chronic, non-communica-
ble diseases [5]. In 2004, 77% of the Australian popula-
tion reported at least one long-term condition and more
than 80% of those in the older age groups had three or
more long-term conditions [5]. In a similar period, over
1.4 million older people in Australia (56% of the older
population) had at least one form of disability, possibly
associated with chronic health conditions that restricted
their everyday activities [6].
Economic consequences of chronic illness
Chronic illness and disability can have damaging, even
catastrophic, socioeconomic effects on individuals and
their households. In Australia in 2003-4, 2.1 million peo-
ple received government disability and sickness related
payments, including over 400,000 recipients of carer
allowances, carer payments and spouse pensions paid to
those caring for a spouse with illness [7]. Furthermore, the
number of people receiving these payments has increased
steadily in recent years--a pattern observed across all
Organisation for Economic Co-operation and Develop-
ment (OECD) countries, with disability and sickness ben-
efit payments now accounting for a significant proportion
of national income [7].
Internationally, there is a well established correlation
between low socioeconomic circumstances, poor health
and well-being [8] and an increased risk of mortality
among those with serious health conditions [9]. Palmer et
al. report that 3 in 10 disabled people live below the pov-
erty line in OECD countries [10]. However, in high
income countries, such as Australia, cushioned with pub-
licly funded health care and social security arrangements,
the economic effects of long-term illness are not as imme-
diately obvious.
Terminology describing and measuring economic hard-
ship, or economic consequences, of chronic illness varies.
One approach is to measure at the macroeconomic level,
direct costs (i.e., costs to the health sector), indirect costs
(i.e., lost production due to disability/illness and prema-
ture death), and intangible costs (i.e., psychological con-
sequences of illness) [11,12]. Using this macroeconomic
analysis, the costs of chronic illness and their risk factors
range globally from 0.02 per cent to 6.77 per cent of Gross
Domestic Product (GDP) [12].
The alternative approach focuses on the impact of illness
at a microeconomic level (i.e., individuals and house-
holds). This characterises much of the research conducted
in Australia, particularly in the social welfare literature,
which shows a significant correlation between financial
stress, disability and poor physical and mental health
[13,14]; and between poverty rates (defined in narrow
income terms) and the disability (handicap, a long-term
condition or chronic illness) [15]. In his recent study on
the costs of disability, derived from the analysis of the
1998-99 Household Expenditure Survey (HES) data,
Saunders [15] estimates the costs of disability to be
approximately 29 per cent of household income, which
increases up to 49 per cent for those with a severe restric-
tion; and suggests the poverty rate among those with a dis-
ability can be six times higher than those without a
disability. Saunders argues that existing income support
arrangements for people with a disability is far from suffi-
cient to maintain a minimum standard of living.
During a preliminary literature review we found no Aus-
tralian qualitative research that examined the economic
impact of chronic illness. The most relevant investigation
of this topic is the Senate Community Affairs Committee's
recent report on cost of living pressures for older Austral-
ians [16]. The report provides timely insights into the
types of economic hardship that older people and their
households face in everyday life as a result of illness.
Snapshot of the Australian health and social welfare 
system
Australia has a national system of health insurance,
known as Medicare, which guarantees free public hospital
treatment based on clinical need for all Australians. Medi-
care is operated by the Australian (national) Government.
Public hospitals are operated by state/territory govern-
ments and the Australian Government meets a share of
the public hospital costs in return for the Medicare guar-
antee. In addition Medicare rebates some of the costs of
medical and some nursing and allied health services pro-
vided by practitioners in private settings on a fee-for-serv-
ice basis. This arrangement extends to in-hospital services
provided on a private basis. Primary care services provided
by general practitioners are funded through this latter
arrangement. Providers may set their own fees, with
rebates attached to a government determined schedule.
Patients may then be required to meet the difference
between the provider's fee and the rebate, however many
services are provided at no charge to the patient. The cost
of certain prescribed medications is also subsidised under
Medicare [17,18].BMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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The social welfare system is administered separately from
Medicare. Persons in receipt of certain welfare payments
(e.g., age or disability pensions) receive higher rebates for
medical services and pay less for prescribed medications.
Medicare covers the costs of professional services only and
does not include treatment supports (e.g., home oxygen,
aids and appliances); state governments provide some or
all of these services, usually with a means test [19].
As a result of these complex arrangements, patients often
find themselves faced with out-of-pocket expenses, receive
different community supports depending on where they
live and often find that important medical support for
their treatment is not available.
The Serious and Continuing Illness Policy and Practice 
Study (SCIPPS)
SCIPPS was designed to develop policy and health system
interventions to support the provision of optimal care for
patients with chronic illness and their carers [20]. SCIPPS
focuses on complicated diabetes, chronic heart failure
(CHF) and chronic obstructive pulmonary disease
(COPD) as the three most common, costly and consistent
conditions that have discrete intervention points along
the continuum of care and strong evidence of successful
intervention.
One of the key objectives of SCIPPS is to engage health
care providers, users, communities, funders and policy
makers in developing best practice health care arrange-
ments for chronic disease care through policy and system
interventions. Initially, a qualitative study was conducted
to develop a comprehensive understanding of the experi-
ences of patients and carers affected by the index condi-
tions to inform patient-centred policy development. The
analysis indicated that people affected by chronic illnesses
act purposefully to balance their quality of life with the
impact of their diseases, which we called "balancing life
and illness" (BLI) [21]. While experiencing a state of ten-
sion between the desire to lead a normal life and the con-
straints imposed by their illnesses, patients and carers had
to weigh competing priorities and make decisions about
courses of action to strike a balance between the manage-
ment of their chronic condition and activities that are
important to them in getting on with their lives.
The purpose of this paper is to report the findings of the
secondary analysis of the qualitative data focusing on the
economic hardship--recognised as one of the key chal-
lenges that interfered with the process of BLI, its meaning
as well as the key factors that contribute to and exacerbate
economic hardship, based on the experiences of those
who are affected by chronic illness. Economic hardship in
this paper is defined as perceived economic difficulties
that arise as a result of chronic illness and influence the
way in which people affected by illness live and manage
their conditions.
Methods
Data collection occurred between March 2007 and Janu-
ary 2008 in the Australian Capital Territory (ACT) and
Western suburbs of Sydney. Semi-structured, in-depth
interviews were conducted with patients and with carers;
each interview running between 45 and 90 minutes.
Patients and carers then completed a 10 minute demo-
graphic survey, which contained information about the
patient's health conditions and health care encounters.
During the survey, participants were also asked about
financial issues including: their current work status,
whether or not they are experiencing financial difficulties
or under financial pressure, and whether they receive any
government financial benefits.
Patients were recruited through referrals from general
practices, local hospitals, community health services, spe-
cialist clinics, health care consumer organisations, and
Aboriginal health services located in the two regions.
Patients were included in the study if they were aged
between 45 and 85 years, had one or more of the three
index conditions that required long term medical inter-
ventions and were deemed to be seriously ill according to
their referring clinician. Purposive sampling was used to
achieve variation in patient characteristics including age,
diagnosis, geographical location, Indigenous status and
cultural and linguistic background. Carers were defined as
the most centrally involved family member or close friend
providing practical and emotional assistance to the
patient. Carers were recruited using convenience sam-
pling, primarily through their care recipient (9 of 14 car-
ers) and through the health professionals at the centres
listed above. Sixty-six of 80 patients and carers
approached agreed to participate in the study (82.5%
response rate).
Ethics approval was granted by the Australian National
University Human Research Ethic Committee, the ACT
Health Human Research Ethics Committee, the University
of Sydney Human Research Ethics Committee and the
Sydney West Area Health Service Human Research Ethics
Committee. All individuals gave informed consent prior
to participating.
The patient and carer interviews began with a question
asking the participant: 'what it is like to live (or care for
someone) with chronic illness', followed by questions
about the challenging and helpful aspects of their experi-
ence. The research team judged sufficient data had been
gathered when interviews no longer provided new
insights or ideas central to the patients' and carers' experi-
ence, indicating data saturation had occurred [22].BMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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All interviews were electronically recorded and tran-
scribed verbatim. The data were analysed using qualitative
content analysis [23], assisted by a computerised qualita-
tive data analysis program, QSR NVivo7 [24]. Using the
NVivo 7 matrix function, the relationships between the
key issues of economic hardship and demographic and
clinical characteristics were examined. Descriptive analy-
sis of the survey data was undertaken using SPSS version
15 [25].
Lincoln and Guba's [26] criteria were used to maximise
the reliability and validity (i.e., the credibility, transfera-
bility, dependability, and confirmability) of the data and
the following analysis including: extensive researcher
training and practice in interview skills and data analysis,
data management using NVivo7 [24], use of a pilot to
assure adequacy of the data collection tool and recruit-
ment strategies, development of protocols and a coding
scheme, establishment of inter-coder reliability, and
examination of qualitative data against relevant survey
data.
Results
Characteristics of participants (survey data)
Fifty-two patients and fourteen carers participated in the
study. Most of them were older than 65 years (n = 42)--on
average 69 years old for patients and 63 years old for car-
ers; were born in Australia, New Zealand or UK (n = 50);
had more than a decade-long history of chronic illness
(mean = 16.5 years); and had monthly or more frequent
contact with general practitioners (GP). Fifty-nine partici-
pants (89.4%) were not in paid employment (i.e., com-
pletely retired/on pension, or unemployed). A similar
number of participants (n = 58) were receiving some form
of government financial benefits at the time of the inter-
view. Detailed characteristics of the participants are sum-
marised in Tables 1 and 2.
Table 1: Characteristics of study participants
Categories Sub-categories Patient (n = 52) §Carer (n = 14)
Residence Australian Capital Territory 26 (50%) 6 (43%)
Sydney West 26 (50%) 8 (57%)
Gender Male 28 (54%) 1 (7%)
Female 24 (46%) 13 (93%)
Age Up to 64 years 17 (33%) 7 (50%)
65 years and over 35 (67%) 7 (50%)
Special groups αCulturally & linguistically diverse background 11 (21%) 5 (36%)
Indigenous Australians 7 (14%) 0
Marital Status Married/de facto/living with a partner 29 (56%) 13 (93%)
βDiagnosis Type 2 diabetes 27 (52%) *7 (50%)
Chronic heart failure 20 (38%) *4 (29%)
Chronic obstructive pulmonary disease 17 (33%) *7 (50%)
More than one index condition 11 (21%) *3 (21%)
Average length of illness (years) 16.5 *21.4
Other co-morbid conditions 43 (87%) *11 (86%)
Visit to GP Monthly or more often 35 (67%) *12 (86%)
Bi-monthly or less frequently 17 (33%) *2 (14%)
Family Carer Have a family carer #22 (42%) Non applicable
Average length of caring (years) #14.7 12.5
Carer receives financial assistance #5 (23%) 5 (36%)
Carer receives informal support #14 (64%) 9 (64%)
α Born in one of the following countries: Finland, France, Germany, Hungary, Turkey, Syria, South Africa, Philippines, Malaysia, Samoa, Hong Kong, 
China
β The total number combines more than 52 because ten patients had two of the index conditions and one patient had all three conditions
§ Nine carers were spouses or offspring of the patients interviewed
* Denotes the carer's account about the patient's condition and management
# Denotes the patient's account about the carerBMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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Costs associated with the management of chronic illness
was raised by eighty-two per cent of patients and carers (n
= 54) as one of the key challenges they faced. Sixty-four
per cent (n = 42) indicated that they experienced financial
hardship, caused by the costs of illness management and
caring responsibilities, which they believed negatively
impacted on their quality of life.
Economic consequences (matrix of the interview and 
survey data)
Content analysis of the interviews revealed that partici-
pants experienced the economic impact of chronic illness
in terms of their ability to afford necessary medical care
and treatments (Affordability of treatment) and recom-
mended self-management activities and basic living costs
(Affordability of other things). Table 3 illustrates the key
characteristics and the frequency of participants who
raised the affordability issues as negative factors during
the interviews. When the two sites (Western Sydney and
ACT) were compared, a considerably higher number of
the ACT participants identified the affordability of treat-
ment as a contributing factor in their economic hardship.
More CHF and COPD patients reported economic hard-
ship as a result of their illness than those with diabetes.
Also, the majority of participants who were currently on
medication, had co-morbidities and were not in paid
employment reported that they had experienced eco-
nomic hardship.
Three key themes from the interviews are described in
detail below.
Affordability of treatment
Affordability of treatment referred to participant's ability
to pay for any treatment, service and care required to man-
age their chronic conditions and its consequences.
Patients and carers expressed concerns regarding ongoing
financial pressures due to high costs involved in the treat-
ment and management of chronic illness (i.e., out-of-
pocket costs for medications, oxygen, regular check-ups,
blood sugar level testing kits, specialist and other medical
care), often accompanied by existing economic con-
straints and lack of support resources. For example,
Our total income of meagre savings has been taken with
payment for food, rent, and healthcare costs. These include
a large bill each month for essential heart medicines, but
also the costs of frequent consultations with GP and con-
sultant cardiologists. These visits lead to the expense of oft-
repeated laboratory tests, including vital INR readings, rou-
tine blood tests for digoxin levels, diabetes, ECGs, heart
scans, a mechanical valve, and a few check-ups on the pace-
maker. (Man in his late sixties with CHF)
Financial pressures also arose from other treatment costs
and the need to make home modifications or purchase
necessary assistive equipment for disease management.
Table 2: Participant characteristics associated with economic status
Characteristics Patients (n = 52) Carers (n = 14)
Work Status
Full-time or part-time employed 2 (3.8%) 2 (14.2%)
Self-employed 2 (3.8%) 0
Partially retired 1 (1.9%) 0
Completely retired pensioner 40 (76.9%) 7 (50%)
Disabled/sickness pension 6 (11.5%) 0
Looking after home/family 1 (1.9%) 5 (35.7%)
Government Financial Benefits (multiple responses)
Disability Support Pension 10 (9.7%) 0
Mobility Allowance 1 (0.9%) 0
Health Care Card 12 (11.7%) 2 (7.4%)
Pensioner Concession Card 28 (27.2%) 6 (22.2%)
Unemployment Benefit 1 (0.9%) 0
Aged Pension 25 (24.3%) 6 (22.2%)
Sickness Allowance 1 (0.9%) 1 (3.7%)
Veteran's Affairs Disability Pension 3 (2.9%) 0
Commonwealth Seniors Card 18 (17.4%) 3 (11.1%)
None 4 (3.9%) 4 (14.8%)
Other (unable to describe) 0 5 (18.5%)
αExperiencing financial difficulties (Yes) 31 (60%) 11 (79%)
α Whether or not participants perceived to have financial difficulties, or were under any financial pressure due to the costs associated with the 
chronic illnessBMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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You can't walk anywhere, it's taxis everywhere you want to
go, with the oxygen cylinder, plus the cost of the oxygen and
the oxygen cylinder rental. I think that's disgusting. The cyl-
inder is $7.40 a month to rent. The valve on the top which
makes the oxygen last longer is $50 odd a month. I think
that is very expensive for the mobility. (Woman in her
early eighties with COPD)
Such circumstances limited the individual's capacity for
health related decision making and for engaging in other
desired pursuits. Some patients prioritised essential treat-
ment options and/or medications based on their under-
standing of urgency and importance, rather than being
guided by health professionals. This meant some prescrip-
tions were not filled or compliance with medication
regimes was compromised. For example,
There are three medications, taken from the pharmacy ...
it's not just one kind of tablets but three kinds, and it's very
expensive. ... There are times, I have to make a decision
whether it's medication, or food, or whatever, pay the bills
and that, so and sometimes, we don't have enough money,
and then we rely on our children to make up the bills and
that, and sometimes we don't fit the medicines, one time we
miss it until we get enough money, and then get it the next
time. (Migrant wife carer of a husband with compli-
cated diabetes)
On rare occasions, participants, like the carer above, reluc-
tantly sought financial help from family members, or
used birthday/anniversary gift vouchers to ease financial
pressures, which was frequently still insufficient to fulfil
needs.












ACT (32) 17 13 22 8
Sydney West (34) 11 16 20 7
Indigenous Australians (7) 44 5 3
§CALD (14) 45 7 2
ΔCHF (24) 91 5 1 6 8
ΔCOPD (23) 10 11 17 4
ΔDiabetes (35) 14 14 21 7
Co-morbidity (49) 16 22 28 10
Female (37) 16 15 23 8
Male (29) 12 14 19 7
ΦOn Medication (58) 26 28 39 15
Not in paid employment^ 
(59)
25 26 38 13
α Affordability of treatment included individuals' capacity to pay for medications, health check-ups, appointment with health professionals, other 
medical care expenses, etc.
β Affordability of other things included individuals' capacity to pay for basic living expenses, healthy food, exercise and gym memberships, social 
activities and transport, etc.
* Participants who responded either in terms of affordability of 'treatment' or 'other things'
# Participants who responded both in terms of affordability of 'treatment' and 'other things'
§ Culturally & Linguistically Diverse background
Δ Some participants have more than one index condition; the total is larger than the total sample size
Φ Patients currently on medication for their chronic condition
^ Participants who were not in any form of paid employment at the time of the interviewBMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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Due to financial constraints participants were often una-
ble to follow their management plans or proactively
engage in secondary prevention activities (e.g., regular
check-ups and seeking timely medical attention).
Affordability of other things
Affordability also related to participants' ability to pay for
additional necessities required for the management of the
illness, such as: healthy food, exercise and gym member-
ships and joining social activities. There was a common
view among participants that maintaining a healthy life-
style is more expensive. For patients with diabetes, pre-
venting (and treating) foot ulcers required additional
costs.
Shoes would be a little more expensive. You have to watch
carefully the sorts of shoes that you wear, so you are paying
more. I think my last pair of shoes was close to $200. So,
footwear can be expensive. You go to a podiatrist, which you
probably wouldn't normally do, if you didn't have diabetes.
(Female, in her seventies, with diabetes)
Cost of accessing health services was frequently men-
tioned by the participants as a source of economic hard-
ship. For example,
Parking, as you know, in the city is very expensive, $27 or
something for three hours or something. So what we do?
We rotate the parking there, we go park, and then after an
hour or so, then my daughter will go and shift the car
round, go and check, and then keep on ... so it's a bit too
much for us financially, we are not coping. (Wife carer of
a husband with diabetes)
For me I can't walk for so long because my legs are sore.
And it takes me about 35 to 40 minutes to walk from home
to Auburn station. So I can't walk there. And, if I take a
taxi it costs me about $8 to $10. So it's too expensive. ... If
I have the subsidy, then I can go to Auburn station by taxi,
and then I can take a train to the city for medical appoint-
ment. (Migrant female, in her seventies, with diabetes)
Participants reported limiting discretionary spending, cut-
ting back on more expensive, healthier foods and reduc-
ing participation in regular exercise programs at a gym.
Participants did prioritise expenditure on essential treat-
ment, but a limited financial capacity meant many had to
compromise in other areas, such as paying for vacations,
home renovations and other activities considered impor-
tant elements of their quality of life. Additional incidental
expenses were amplified by the hardship, resulting in a
need to make choices between expenditure for health care
and other everyday expenses. This meant that paying even
the bare minimum of living costs presented challenges.
For example,
When the house is broken, we like to call somebody to fix,
but we can't, because we keep the money for the medicine.
So we cannot spend the money to the other thing. Like my
car is not very good, broken, but we keep it like this, because
we cannot pay everything. (Migrant wife carer of a hus-
band with diabetes)
Others had to give up leisure activities, hobbies, or cut
down associated expenditures, for example,
I'm a painter, it's my life. But I'm suddenly, the first time
in my life, I can't afford...I think twice about buying [paint-
ing] materials. (Man in his late sixties with CHF)
I don't waste my pension. I don't spend it on things. I don't
buy magazines. I don't go to the hair dresser. I don't go out
a lot. (Woman in her seventies with COPD)
Most carers were the spouse of their care recipient (n =
10), and/or living in the same house (n = 13), hence they
shared similar concerns to patients regarding their eco-
nomic hardship. Some carers were concerned about the
negative financial impact on the household of taking time
off of work to care for a loved one and the burden that
transportation costs imposed.
Factors that influenced economic hardship
Factors that influenced whether participants experienced
economic hardship included: eligibility for pensions,
other government subsidies or allowances (e.g., pension,
carer allowance, health care card or Department of Veter-
ans' Affairs Gold Card, Oxygen subsidy scheme), and/or a
concession card (for additional discount rates for electric-
ity, water and other home care services). For example,
I'm lucky there. The medicines, because I'm on a pension,
thankfully, I get them for $4.90. But if I wasn't on the pen-
sion, I don't know whether I could afford to pay what some
of these medicines cost. I've got a puffer there that's $77,
but I get it for $4.90. (Woman, in her seventies, with
COPD)
Most participants who were eligible for pensions or other
government subsidy were grateful for use schemes, for
example "I'm surviving financially because of the welfare
system". However for some, this support was still inade-
quate to overcome economic hardship and any additional
costs not covered by Medicare or other support measures
posed an economic burden on their life. For example,
I walked in there [chemist] last time to get my Webster
Packs for a month and I got an unexpected bill for $85 and
that was hard. I'm on one or two over the counter medica-
tions and they're not funded by Government. (Man, in his
early sixties with CHF and diabetes)BMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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However desperate my low income situation, I have been
warned that the pacemaker will have to be replaced in due
course and it would be fool-hardy to attempt stopping my
heart drugs in order to redeem my now less-than-basic pen-
sion. (Man in his late sixties with CHF)
For those who were ineligible for pensions or government
subsidies, often due to their means tested income exceed-
ing the eligibility criteria, economic hardship was severely
felt and was reported to impact significantly on their ill-
ness management. For example,
I mention it to her [doctor], "we can't buy the medicine
that you prescribed, because we haven't got money", and
she said well "I know, well that's why [your] husband blood
sugar level is high, because he's not taking the tablets",
because I can't buy them from the pharmacy, so ... and we
don't have the card, the concession card that reduces the
price of the medication, so what do we do? (Migrant carer
whose husband has diabetes)
You don't have support anywhere and you are not really
highly paid. But you are paid anyway high enough that
there is no help ... that was the time that - a few years ago.
Now I am actually on a pension and all that. Like, medica-
tion side has improved. I had four different medications, so
I paid quite a bit around that time and all others and pay-
ing rent and all these expenses of the life too. That was
when I was working. (Woman, in her sixties, with diabe-
tes)
In addition, a lack of flexibility in health care services
influenced whether participants experienced economic
hardship because eligibility criteria were not always inclu-
sive of those most in need. For example, to be eligible for
an oxygen subsidy scheme (free, limited, oxygen support
for people with COPD) patients would have to be a per-
manent resident of the ACT. Hardship was exacerbated
when patients had 'co-morbidities' or 'multi-morbidities'
with the cost of illness management increasing as more ill-
nesses were being managed. The level of health literacy, in
terms of patients' and carers' awareness of the system and
services, also played an important role in the ability to
access subsidies, income support or other available bene-
fits (e.g., free oxygen, community transport or taxi vouch-
ers). Lack of knowledge of self-care added economic
hardship, costing both the participants and the health care
system. For example, a patient with CHF developed pul-
monary oedema and was admitted to hospital due to her
lack of understanding of diet. She said,
Last time when I went into hospital I was drinking four and
five cups of Milo a day plus water. I didn't realise Milo was
a drink; I thought it was a food. (Woman, in her eighties,
with CHF)
As a consequence of experiencing financial pressures, par-
ticipants reported the need to be extremely vigilant with
expenses and to limit physical and social activities in
order to minimise economic hardship and maintain some
capacity to act on lifestyle risk factors and balance their
life and illness management requirements.
Discussion
Earlier qualitative studies of chronic illness experiences
[27-30] support what has been found in our study regard-
ing the kinds of economic hardship associated with man-
aging chronic illness. These include the individual's
compromised ability to afford not only essential treat-
ment and medication but also to maintain a healthy life-
style and quality of life. Managing serious, long-term
conditions requires ongoing financial commitments
regardless of the individuals' economic capacity. Despite
a health care system that provides universal coverage and
a well established and extensive system of social security,
individuals with chronic illness still face the long term
prospect of economic hardship and severe quality of life
impairment. There is evidence in this study that individu-
als in these circumstances lack adequate resources and
support to negotiate and overcome these challenges.
The findings confirm that economic hardship seriously
compromises people's healthy lifestyle choices, for
instance, due to participants' inability to afford fresh fruit
and vegetables that are often more expensive than proc-
essed food with higher fat, sugar and sodium content.
There appears to be a potential risk that people with
chronic conditions, in particular those already exposed to
long-term economic hardship, will be more seriously
impacted by the global economic downturn. Further
research in this area is necessary to investigate any causal
relationship with this phenomenon.
This study adds to previous research by identifying a
potential risk group for whom the impact of economic
hardship on their management of chronic illness was
reported as greater relative to others in this study, and
which may be jeopardised further by the economic down-
turn. The groups most at risk include those who are: not
in paid employment; on multiple medications; experienc-
ing co-morbidity; from culturally and linguistically
diverse (CALD) or Indigenous backgrounds; and/or not
eligible for government subsidies and financial support
(e.g., low income employees or an income bracket neither
sufficiently low for government subsidy eligibility nor
high enough to afford necessary expenses; or self-funded
retirees without good cash reserves). Interestingly, our
study suggests that the problems associated with eco-
nomic hardship are not geographically specific and are
not restricted to locations known to have higher concen-
trations of residents with lower socioeconomic statusBMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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(SES). Whilst the ACT population is relatively evenly dis-
tributed across SES groupings, with few lower SES pockets
[31], a considerably higher number of the ACT partici-
pants experienced economic hardship due to costs
involved in medical treatment and care. This indicates to
policymakers that they cannot assume compensating
measures for economic hardship can continue to be based
on traditional geographic assessments of SES.
The study highlights the diversity of factors influencing
economic outcomes when faced with chronic illness and
adds value to the existing literature in the area by offering
a qualitative perspective to understanding this issue.
Whilst in principle economic hardship can derive gener-
ally from either loss of income or costs of care to patients
and their carers, such impacts are potentially mediated by
multiple individual, community and social levels varia-
bles. Indeed, Saunders [15] argues that there are limita-
tions of relying on simply income based measures of
economic hardship.
Although not explored in detail by this study, participants
discussed some coping strategies to manage their ongoing
economic hardship. One strategy discussed was prioritis-
ing essential treatments or living expenses, including
those related to their care and management. However,
participants still had to make a choice between purchas-
ing essential treatments and medications and paying for
basic living expenses as most could not afford both.
Recent Australian studies provide similar results. Hynd et
al. investigated the impact of a co-payment increase for
dispensing Australian Government-subsidised medicines
and found a significant reduction in the patient's ability to
afford essential medicines following the initiative [32]. In
the 2008 Commonwealth Fund International Health Pol-
icy Survey, 36% of Australian participants (n = 593)
reported access problems (accessing physicians, filling
prescriptions, or getting recommended test, treatment, or
follow-up) because of cost [33]. The Menzies Centre for
Health Policy's (MCHP) national survey (n = 1,200) con-
ducted in 2008 confirmed these findings [34]. In addi-
tion, the MCHP survey found that high levels of financial
stress actually lower individuals' confidence in the sys-
tem's capacity to provide safe and quality care [34].
Internationally there are an increasing number of studies
which report often catastrophic economic consequences
associated with chronic illness in low and middle income
countries [35-37]. Xu and colleagues in their examination
of data from household surveys in 59 countries, argue that
middle and low income countries in particular ought to
address gaps in their health policy in terms of available
health services, health insurance, out-of-pocket payments
and financial risk protection to minimise catastrophic
health expenditures and potential consequences of
impoverishment [37]. The findings in this study indicate
the need for further research on the nature of catastrophic
health spending among people with chronic, complex
conditions and its relationship with health policies in
developed countries such as Australia in which such phe-
nomenon is often overlooked.
The main limitations of our study include the lack of gen-
eralisability of data obtained from two local areas of Aus-
tralia, mostly urban; a small sample size and convenient
sampling of carer participants. However, the aim of this
secondary analysis was to inform the development of pol-
icy interventions that are sensitive to the local context and
time. Given that participants were mostly older people,
some of the economic impacts of chronic illness unique
to younger populations--such as a loss of income due to
inability to work and its consequences--were not raised as
a key issue, hence not fully explored during the interviews.
A further study is warranted looking at younger popula-
tions. We relied upon the participants' descriptions of
their clinical conditions and their management through
the interview and the questionnaire. However the partici-
pants were recruited through their primary clinicians and
we were able to establish the participants had the index
condition(s) with moderate to severe symptoms. As a
qualitative inquiry, the study focused largely on individ-
ual participants' rich descriptions of their experience.
Given the limitations above, caution is necessary in gener-
alising the findings. However, this research fills a gap in
the chronic illness literature by providing an understand-
ing of the economic impacts of managing chronic condi-
tions and the hardship that patients and families
experience as a result. It provides a platform for further
research into strategies to improve the affordability of ill-
ness management, particularly self-management activi-
ties, given the significant role they play in controlling the
progression of illness. In addition, it highlights a need to
critically appraise current health, social and welfare policy
in order to identify possible options for alleviating hard-
ship. This will require the following:
1. A detailed investigation of the different dimensions of
economic hardship experienced by households affected
by chronic illness to measure the scope and scale of the
hardship, the coping strategies employed to manage and,
where possible, to overcome the hardship.
2. An economic evaluation of subsidising secondary pre-
vention measures (e.g., food, exercise and transport) with
additional funding for medical costs (e.g., medication,
oxygen and health care equipment), in comparison with
health care services provision for those who end up in
hospital due to failures in existing primary care and social
support arrangements.BMC Health Services Research 2009, 9:182 http://www.biomedcentral.com/1472-6963/9/182
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3. A review of current eligibility criteria for health and
social care and other support policies associated with
funding subsidies for people with chronic illness, in par-
ticular those with multi-morbidity.
It is important to note that the study was undertaken in
late 2007 and early 2008, before the major impact in Aus-
tralia from the Global Financial Crisis (GFC). The eco-
nomic hardships articulated by interviewees are therefore
not simply a result of the deteriorating economic environ-
ment; hence suggest a systemic rather than a transient
problem in this area. There are mixed theories about the
impact of GFC on health in terms of mortality and mor-
bidity rates as well as the health care system's response/
reaction (i.e., workforce, health expenditure) [38,39]. The
study findings however highlight the negative conse-
quences of economic hardship caused by long-term costs
of chronic disease management on the individual's capac-
ity to effectively continue to manage their chronic condi-
tions. In a climate of global economic instability--leading
to, for example, increased unemployment, job insecurity,
and loss of income--policy makers, health service provid-
ers and practitioners need to be more vigilant on issues of
care management affordability.
Conclusion
The study is the first Australian qualitative inquiry that
explored the economic impact of common chronic ill-
nesses (COPD, CHF and diabetes) based on the percep-
tions of patients and family carers. This research provides
both insights on the economic stressors associated with
managing chronic illness and evidence that such eco-
nomic hardship requires households to make difficult
decisions between care and basic living expenses, which at
times compromises necessary treatments and health care.
Acknowledging the limitations of the study, the findings
underscore the need to consider the cost of lifestyle
changes required as part of chronic disease management
in developing future policy to address economic hardship
among people affected by chronic illness. Further research
is necessary to explore the ways in which people cope with
economic hardship and prioritise conflicting demands to
balance between managing chronic illness and living a
normal life. Future research should focus on developing
an understanding of health care decisions that are likely to
cause less than optimal health outcomes and result in
increased costs to the health system.
For health care practitioners these insights are fundamen-
tal to providing appropriate and flexible care for chroni-
cally ill patients and support for their families. The
findings highlight the need to examine in-depth, and even
to challenge, common perceptions of the economic
impact of chronic illness with respect to geographic or
government jurisdictional boundaries. Future policy
needs to be multi-sectoral, focusing not only on clinical
issues but also on the individual, their household and
economic capacity to manage chronic illness.
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